NO20010291D0 - Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår - Google Patents

Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår

Info

Publication number
NO20010291D0
NO20010291D0 NO20010291A NO20010291A NO20010291D0 NO 20010291 D0 NO20010291 D0 NO 20010291D0 NO 20010291 A NO20010291 A NO 20010291A NO 20010291 A NO20010291 A NO 20010291A NO 20010291 D0 NO20010291 D0 NO 20010291D0
Authority
NO
Norway
Prior art keywords
acat
atherosclerotic
wounds
administration
treatment
Prior art date
Application number
NO20010291A
Other languages
English (en)
Other versions
NO20010291L (no
Inventor
Thomas Michael Andrew Bocan
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010291D0 publication Critical patent/NO20010291D0/no
Publication of NO20010291L publication Critical patent/NO20010291L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20010291A 1998-07-21 2001-01-18 Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår NO20010291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9363998P 1998-07-21 1998-07-21
PCT/US1999/013948 WO2000004892A2 (en) 1998-07-21 1999-06-18 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions

Publications (2)

Publication Number Publication Date
NO20010291D0 true NO20010291D0 (no) 2001-01-18
NO20010291L NO20010291L (no) 2001-01-18

Family

ID=22239992

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010291A NO20010291L (no) 1998-07-21 2001-01-18 Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår

Country Status (25)

Country Link
EP (1) EP1098662A2 (no)
JP (1) JP2002521328A (no)
KR (1) KR20010083134A (no)
CN (1) CN1310629A (no)
AP (1) AP2001002035A0 (no)
AU (1) AU4701799A (no)
BG (1) BG105162A (no)
BR (1) BR9912296A (no)
CA (1) CA2335062A1 (no)
CZ (1) CZ2001126A3 (no)
EA (1) EA200100153A1 (no)
EE (1) EE200100046A (no)
HR (1) HRP20010055A2 (no)
HU (1) HUP0102880A3 (no)
ID (1) ID30030A (no)
IL (1) IL140982A0 (no)
IS (1) IS5809A (no)
NO (1) NO20010291L (no)
OA (1) OA11584A (no)
PL (1) PL346011A1 (no)
SK (1) SK502001A3 (no)
TR (1) TR200100205T2 (no)
WO (1) WO2000004892A2 (no)
YU (1) YU3501A (no)
ZA (1) ZA200100294B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2382676A1 (en) * 1999-11-05 2001-05-17 Warner-Lambert Company Prevention of plaque rupture by acat inhibitors
DOP2000000107A (es) 1999-12-01 2002-09-16 Agouron Pharmaceutical Inc Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas
AU2268401A (en) * 1999-12-17 2001-06-25 Versicor Inc Novel succinate compounds, compositions and methods of use and preparation
PL362244A1 (en) * 2000-09-01 2004-10-18 Sankyo Company, Limited Medicinal compositions
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
CA2479906C (en) * 2002-04-03 2011-02-08 Topotarget Uk Limited Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
CA2492035A1 (en) * 2002-07-11 2004-01-15 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
WO2011092284A1 (en) * 2010-01-29 2011-08-04 Euroscreen S.A. Novel amino acid derivatives and their use as gpr43 receptor modulators
CN104211695B (zh) * 2013-06-04 2017-04-12 中国医学科学院医药生物技术研究所 一组胺甲酰基苯磺酰类化合物的用途
EP3244883A1 (en) * 2015-01-15 2017-11-22 Biocant - Associação De Transferência De Tecnologia Treatment of hutchinson-gilford progeria syndrome and diseases related to vascular ageing
CN106831697B (zh) * 2017-03-15 2019-11-05 深圳市康道生物有限公司 川榛有效提取成分及其在防治动脉粥样硬化中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
EE9800037A (et) * 1995-08-04 1998-08-17 Warner-Lambert Company Sulfaamhappe derivaatide, atsüülsulfoonamiidide või sulfonüülkarbamaatide kasutamine lipoproteiini tasemeid vähendava ravimi valmistamiseks
DK0901466T3 (da) * 1996-05-17 2002-02-18 Warner Lambert Co Biphenylsulfonamid-matriksmetalloproteinase-inhibitorer
BR9711988A (pt) * 1996-09-04 1999-08-24 Warner Lambert Co Inibidores de metaloproteinase de matriz e seus empregos terap-uticos

Also Published As

Publication number Publication date
ID30030A (id) 2001-11-01
TR200100205T2 (tr) 2001-05-21
HUP0102880A2 (en) 2002-06-29
HUP0102880A3 (en) 2002-11-28
CA2335062A1 (en) 2000-02-03
IL140982A0 (en) 2002-02-10
JP2002521328A (ja) 2002-07-16
IS5809A (is) 2001-01-12
PL346011A1 (en) 2002-01-14
KR20010083134A (ko) 2001-08-31
NO20010291L (no) 2001-01-18
EE200100046A (et) 2002-06-17
AU4701799A (en) 2000-02-14
HRP20010055A2 (en) 2002-04-30
WO2000004892A3 (en) 2000-05-18
BG105162A (en) 2001-12-29
WO2000004892A2 (en) 2000-02-03
AP2001002035A0 (en) 2001-03-31
CN1310629A (zh) 2001-08-29
CZ2001126A3 (cs) 2002-01-16
EP1098662A2 (en) 2001-05-16
EA200100153A1 (ru) 2001-08-27
YU3501A (sh) 2005-06-10
ZA200100294B (en) 2002-01-10
OA11584A (en) 2004-07-20
SK502001A3 (en) 2002-06-04
BR9912296A (pt) 2001-04-17

Similar Documents

Publication Publication Date Title
CY2016006I2 (el) Συνδυασμενη χρηση βαλσαρτανης και παρεμποδιστων διαυλων ασβεστιου για θεραπευτικους σκοπους
NO971015L (no) Forbindelser og metoder for behandling av cancer
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
DE60141247D1 (de) Bandkassette und bandeinheit
IT1308739B1 (it) Dispositivo di trattamento di un nastro allungato
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO20010291D0 (no) Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår
IT1277461B1 (it) Procedimento e dispositivo per il trattamento di materiali
ITTO950529A0 (it) Dispositivo e procedimento per la realizzazione di catene di ortidoti lunghezza ridotta
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
DE60144529D1 (de) Bandkassette und bandeinheit
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
ID28797A (id) Tioredoksin dan pemrosesan biji-bijian
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
NO20013651D0 (no) Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner
PT1381620E (pt) Dissacaridos hipersulfatados e metodos de utilizacao dos mesmos para o tratamento de inflamacoes
EE05263B1 (et) IL-18 inhibiitorite kasutamine keskn„rvissteemi kahjustuste raviks v?i ennetamiseks
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
IT1302813B1 (it) Dispositivo per la riduzione diretta di ossidi di ferroe relativo procedimento
NO20000274D0 (no) Behandling av fluider
FIU990291U0 (fi) Laitteisto massan käsittelemiseksi ja sen käyttö
FI19992804A (fi) Laitteisto massan käsittelemiseksi ja sen käyttö

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application